🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is to show if vaccination with autologous dendritic ce...
Status
Completed
Location
Department of Oncology, Copenhagen University Hospital, Herlev
Start Date
2004-09
Trial ID
NCT00197912
Treatments Being Tested
The main purpose of this study was to determine whether ADT started before ...
Status
Completed
Location
Urology Center of Alabama
Start Date
2011-09
Trial ID
NCT01431391
Treatments Being Tested
The study aim to show if vaccination with autologous dendritic cells pulsed...
Status
Terminated
Location
Department of Oncology
Start Date
2004-09
Trial ID
NCT00197925
Treatments Being Tested
This pilot phase I trial studies the side effects of taking ipilimumab afte...
Status
Terminated
Location
Jonsson Comprehensive Cancer Center
Start Date
2014-07-17
Trial ID
NCT02070406
The purpose of this study is to find out what effects (good and bad) immuno...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2018-03-15
Trial ID
NCT03406715
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
St. Elizabeth's Medical Center
Start Date
1999-11
Trial ID
NCT00003977
Current therapeutic approaches available for patients with advanced-stage m...
Status
Completed
Location
Hillman Cancer Center
Start Date
2014-05-16
Trial ID
NCT01876212
Treatments Being Tested
Despite recent advances in the treatment of patients with resected NSCLC, d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT01398124
Treatments Being Tested
Phase Ib clinical trial using autologous dendritric cell (DC) vaccine loade...
Status
Active Not Recruiting
Location
CHUV Oncology Department
Start Date
2022-03-22
Trial ID
NCT05195619
Immune therapies, such as a IL-2, for metastatic renal cell carcinoma (mRCC...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2009-02
Trial ID
NCT00913913
Treatments Being Tested